Neuroimaging research indicates that 'brain age'-the apparent age of the brain on scans compared to chronological age-could become a significant biomarker for diagnosing mental disorders. Many psychiatric conditions exhibit accelerated brain aging, pointing to a measurable biological vulnerability. Unlike traditional symptom-based diagnoses, which can overlap, objective measures like brain age may enhance classification and enable earlier interventions.
Researchers have connected altered brain age to disruptions in neural networks critical for cognition and emotional regulation. This suggests that quantifying brain age could help clinicians identify specific disorder patterns, predict risks more accurately, and tailor personalized treatment plans.
A comprehensive review of 68 studies found consistent differences in brain age across various mental disorders. Notably, schizophrenia spectrum disorders showed the most pronounced effect, with brain age appearing significantly older than chronological age. Neurocognitive disorders and mood disorders also demonstrated substantial increases in brain age, while neurodevelopmental disorders showed a smaller elevation.
These findings suggest that brain age could serve as a valuable complement to clinical evaluations, potentially improving diagnostic confidence and facilitating earlier detection of illnesses. Future research, including longitudinal studies and the standardization of imaging protocols, will be crucial to validate its reliability and integrate it into routine clinical practice for prognosis and treatment monitoring.